- English (USA)
- English (UK)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
ViroGates A/S (VIROG)
The ViroGates share price today is 7.10, view CSE VIROG stock exchange data. Track the latest ViroGates share price with real-time updates on VIROG stock performance including market cap, day range, 52-week range and dividend yield. Access VIROG charts, earnings dates and analyst estimates to support your investment decisions.
Copenhagen
Currency in DKK
7.10
-0.50(-6.58%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
6.80
7.40
52 wk Range
6.70
17.40
VIROG is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
6.807.40
52 wk Range
6.7017.40
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
VIROG Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Stock has taken a big hit over the last week
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
ViroGates A/S Earnings Call Summary for Q2/2026
- ViroGates H1 2026 revenue surged 173% to DKK 5.1M, driven by large U.S. partner order; operating loss narrowed 33% to DKK 3.9M; shares rose 6.4%.
- Company shifting from direct clinic sales to partnership-led distribution model; cash position strengthened to DKK 17.6M from DKK 11.9M year-over-year.
- Full-year 2026 revenue guidance set at DKK 6.5M-8.0M; H2 expected below H1 due to non-recurring nature of suPARbio order.
- FDA requested additional data for suPARnostic TurbiLatex De Novo application; partner Sobi helping fund regulatory work with minimal cash impact.
- Revenue concentration risk remains high with single partner driving growth; recurring customer base flat at 20, raising concerns about diversification.
Last Updated: 21-08-2026, 03:30 pm
Read Full TranscriptEarnings
Latest Release
06-11-2026
EPS / Forecast
-- / --
Revenue / Forecast
-- / --
Compare VIROG to Peers and Sector
Metrics to compare | VIROG | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipVIROGPeersSector | |
|---|---|---|---|---|
P/E Ratio | −8.1x | 31.3x | −0.2x | |
PEG Ratio | - | 0.86 | 0.00 | |
Price/Book | 4.8x | 2.6x | 2.6x | |
Price / LTM Sales | 7.5x | 2.9x | 2.8x | |
Upside (Analyst Target) | - | 1.0% | 61.2% | |
Fair Value Upside | Unlock | 11.0% | 9.7% | Unlock |
ViroGates A/S, an in vitro diagnostics company, develops and sells blood tests for measuring chronic inflammation for the healthcare sector. It offers suPARnostic TurbiLatex, a CE-IVD approved particle-enhanced turbidimetric immunoassay for quantitative measurement of suPAR in human plasma; suPARnostic AUTO Flex ELISA kit, a fully quantitative immunoassay designed for accurate and reliable measurement of soluble urokinase plasminogen activator receptor in human plasma; and suPARnostic Quick Triage, a test for rapid, quantitative measurement of suPAR levels. ViroGates A/S was founded in 2000 and is headquartered in Birkerød, Denmark.
Ownership
Ownership Overview
Top Holders
FAQ
What Is the ViroGates (VIROG) Share Price Today?
The ViroGates share price today is 7.10.
What is the current ViroGates (VIROG) share price and day range?
As of 15-11-2026, the ViroGates share price is 7.10, with a previous close of 7.10. The share price has ranged from 6.80 to 7.40 today, while the 52-week range spans from 6.70 to 17.40.
What Is the ViroGates Market Cap?
As of today, ViroGates market cap is 65.90M.
From a Technical Analysis Perspective, Is VIROG a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
What Stock Exchange Does ViroGates Trade On?
ViroGates is listed and trades on the Copenhagen Stock Exchange.
What Is the Stock Symbol for ViroGates?
The stock symbol for ViroGates is "VIROG."
How Many Times Has ViroGates Stock Split?
ViroGates has split 0 times.
How Many Employees Does ViroGates Have?
ViroGates has 7 employees.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.